1. Home
  2. DBVT vs NC Comparison

DBVT vs NC Comparison

Compare DBVT & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • NC
  • Stock Information
  • Founded
  • DBVT 2002
  • NC 1913
  • Country
  • DBVT France
  • NC United States
  • Employees
  • DBVT N/A
  • NC N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • NC Coal Mining
  • Sector
  • DBVT Health Care
  • NC Energy
  • Exchange
  • DBVT Nasdaq
  • NC Nasdaq
  • Market Cap
  • DBVT 237.4M
  • NC 247.6M
  • IPO Year
  • DBVT N/A
  • NC N/A
  • Fundamental
  • Price
  • DBVT $9.40
  • NC $38.73
  • Analyst Decision
  • DBVT Buy
  • NC
  • Analyst Count
  • DBVT 4
  • NC 0
  • Target Price
  • DBVT $14.81
  • NC N/A
  • AVG Volume (30 Days)
  • DBVT 41.9K
  • NC 7.9K
  • Earning Date
  • DBVT 07-29-2025
  • NC 08-06-2025
  • Dividend Yield
  • DBVT N/A
  • NC 2.61%
  • EPS Growth
  • DBVT N/A
  • NC N/A
  • EPS
  • DBVT N/A
  • NC 4.61
  • Revenue
  • DBVT $3,497,000.00
  • NC $249,990,000.00
  • Revenue This Year
  • DBVT $1,700.53
  • NC N/A
  • Revenue Next Year
  • DBVT $535.67
  • NC N/A
  • P/E Ratio
  • DBVT N/A
  • NC $8.50
  • Revenue Growth
  • DBVT N/A
  • NC 14.71
  • 52 Week Low
  • DBVT $2.21
  • NC $25.19
  • 52 Week High
  • DBVT $12.78
  • NC $39.65
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 52.73
  • NC 61.44
  • Support Level
  • DBVT $9.00
  • NC $36.58
  • Resistance Level
  • DBVT $10.12
  • NC $39.44
  • Average True Range (ATR)
  • DBVT 0.57
  • NC 1.20
  • MACD
  • DBVT 0.08
  • NC 0.21
  • Stochastic Oscillator
  • DBVT 72.24
  • NC 80.59

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

Share on Social Networks: